<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19380" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cherry Red Spot</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tripathy</surname>
            <given-names>Koushik</given-names>
          </name>
          <aff>ASG Eye Hospital, BT Road, Kolkata, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patel</surname>
            <given-names>Bhupendra C.</given-names>
          </name>
          <aff>University of Utah</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Koushik Tripathy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bhupendra Patel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19380.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>A cherry-red spot refers to a red-tinted region at the center of the macula surrounded by retinal opacification. Cherry-red spots at the macula may be present in various pathologic conditions, including lysosomal storage disorders, retinal ischemia, and retinal infarction. Ruling out life-threatening or sight-threatening diseases is of paramount importance in a patient with a cherry-red spot at the macula. Ruling out serious life-threatening or sight-threatening diseases is crucial in a patient with a cherry-red spot at the macula. The management varies according to the cause. This activity reviews the evaluation and management of patients with cherry-red spots. It highlights the role of interprofessional team members in collaborating to provide well-coordinated care and enhance patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the etiology and pathophysiology of the cherry-red spot at the macula.</p></list-item><list-item><p>Describe the clinical features of the cherry-red spot at the macula.</p></list-item><list-item><p>Review the management of patients with a cherry-red spot at the macula.</p></list-item><list-item><p>Explain the importance of the interprofessional team in diagnosing and evaluating patients with a cherry-red spot at the macula.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19380&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19380">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19380.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The cherry-red spot refers to the reddish area at the center of the macula surrounded by retinal opacification in certain disorders. The retinal opacification may be due to various causes, including accumulation of different materials in the ganglion cells in storage disorders, and retinal ischemia/infarction, as in central retinal arterial occlusion (CRAO). Ruling out serious life-threatening or sight-threatening diseases is paramount in a patient with a cherry-red spot at the macula. The management varies according to the cause.</p>
      </sec>
      <sec id="article-19380.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The causes of the cherry-red spot include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Central retinal artery occlusion (CRAO)- The characteristic presentation of this disease is sudden onset unilateral visual loss in an elderly male or female. The usual cause is an embolism, which blocks the central retinal artery. The embolus may be composed of cholesterol, fibrin-platelet, or calcium. The embolus usually originates from the carotid plaque and, less commonly, from the heart or the aorta. Inflammatory conditions, like giant cell arteritis (GCA), may also cause CRAO, though branch retinal arterial occlusion (BRAO) is not a common feature in GCA. Branch retinal arterioles do not have a continuous muscular coat or internal elastic lamina.<xref ref-type="bibr" rid="article-19380.r1">[1]</xref>&#x000a0;GCA involves only medium and large size arteries, not arterioles (like branch retinal arteriole). However, GCA might affect the cilioretinal artery, a branch of the posterior ciliary artery. On cursory examination, an examiner might mistake cilioretinal arterial occlusion in GCA for a BRAO. Other causes of central retinal artery occlusion include myxoma or vegetation of the cardiac valves, thrombophilic disorders, and retinal migraine. Other associations of CRAO include dyslipidemia,&#x000a0;diabetes, hypertension, smoking, and pyoderma gangrenosum.<xref ref-type="bibr" rid="article-19380.r2">[2]</xref> In an extensive series of 248 eyes of 240 patients with central retinal artery occlusion, the cherry-red spot was present on the initial examination in 90% of permanent CRAO cases.<xref ref-type="bibr" rid="article-19380.r3">[3]</xref>&#x000a0;Retinal whitening and a cherry-red spot are important manifestations of acute CRAO. Other related situations causing a cherry-red spot include:
<list list-type="bullet"><list-item><p>Intraorbital hemorrhage or mass may compromise the choroidal and retinal circulation and lead to a cherry-red spot at the macula</p></list-item><list-item><p>Retrobulbar injections (usually anesthetics) with or without retrobulbar hemorrhage may cause CRAO and a cherry red spot at the macula<xref ref-type="bibr" rid="article-19380.r4">[4]</xref><xref ref-type="bibr" rid="article-19380.r5">[5]</xref></p></list-item><list-item><p>Leukemic infiltrates of the optic nerve head may cause CRAO and cherry red spots<xref ref-type="bibr" rid="article-19380.r6">[6]</xref></p></list-item><list-item><p>Optic nerve avulsion may cause a cherry-red spot at the macula<xref ref-type="bibr" rid="article-19380.r7">[7]</xref></p></list-item><list-item><p>Macular infarction is another cause of cherry red spots at the macula. Causes of macular infarction include trauma,<xref ref-type="bibr" rid="article-19380.r8">[8]</xref>&#x000a0;retinal vascular occlusion, diabetic retinopathy, intravitreal gentamicin or amikacin,&#x000a0;systemic lupus erythematosus, and sickle cell anemia.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Tay-Sachs disease (GM2 gangliosidosis type 1, infantile&#x000a0;amaurotic familial idiocy, B variant GM2 gangliosidosis)- This is the most common type of gangliosidosis due to deficiency of the alpha subunit of hexosaminidase A on chromosome&#x000a0;15q23. The disease has&#x000a0;an onset of symptoms in infancy. There is an abnormal accumulation of gangliosides in the brain and ganglion cell layer of the retina. The disease is fatal, and most affected children die within the first 2 to 5 years of age. This neurodegenerative disorder is inherited in an autosomal recessive fashion. The child usually has a developmental delay. Other features include a cherry-red spot at the macula in both eyes,&#x000a0;increased startle response, poor head control, seizures, dementia, apathy, hypotonia, deafness, blindness, and late hypertonia.<xref ref-type="bibr" rid="article-19380.r9">[9]</xref> Incidence is very high in Ashkenazi Jews, at around 1 in 3500 to 4000 births. A cherry-red spot is present in approximately 90% of the patients affected by the disease.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>GM2 gangliosidosis type 2 or Sandhoff disease is due to&#x000a0;mutation of the beta subunit of hexosaminidase at chromosome 5q13. Reports describe infantile, juvenile, and adult forms. It is inherited autosomal recessively. The cherry-red spot is present in a majority of cases. Clinical features are similar to Tay-Sachs disease.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Commotio retinae - After blunt trauma, acutely retinal opacification may occur.<xref ref-type="bibr" rid="article-19380.r10">[10]</xref>&#x000a0;When this retina whitening involves the macula, it is called Berlin's edema. Although actual retinal thickening is not present, this macular whitening can cause a pseudo-cherry red spot.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Niemann-Pick disease - Type A and B result from the deficiency of acid sphingomyelinase enzyme, a product of the SMPD1 gene (sphingomyelin phosphodiesterase-1) on chromosome 11p15.4. There is an accumulation of sphingomyelin in the tissues. The cause of Niemann-Pick disease type C1 and type D is a mutation in the NPC1 gene on chromosome 18q11. Niemann-Pick disease C2 is due to a mutation in the NPC2 gene at chromosome 14q24.3. Both NPC1 and NPC2 genes are involved in the transport of lipids (LDL cholesterol or low-density lipoprotein cholesterol) in endosomes and lysosomes.
<list list-type="bullet"><list-item><p>Type A disease (classic infantile) has an early onset and severe neurodegeneration. Hepatosplenomegaly may be present in early infancy, and there may be a failure to thrive and a suboptimal weight gain. The developmental milestones may be normal until the first birthday, after which there may be psychomotor regression or progressive loss of mental abilities and motor performance. Interstitial lung disease may be noted, and death usually occurs in early childhood. Most of the affected children have&#x000a0;a cherry-red spot at the macula.</p></list-item><list-item><p>Type B, usually (visceral), has a normal function of the central nervous system (CNS). Disease onset is usually in the mid-childhood, and presentation is similar to but less severe than type A.&#x000a0;Features include short stature, hepatosplenomegaly, recurrent pulmonary infections, and thrombocytopenia. Some patients may have mixed features of type A and B. Cherry-red spot at the macula is noted in around 1/3rd of cases.&#x000a0;</p></list-item><list-item><p>Type C (subacute/juvenile) has a slowly progressive disease and moderate CNS damage. Features include ataxia, speech and swallowing difficulty, vertical supranuclear gaze palsy, dystonia, interstitial lung disease, intellectual decline, and seizures.</p></list-item><list-item><p>Type D (Nova Scotia form noted in individuals from Nova Scotia of Canada who have an Acadian ancestor) is associated with late-onset disease but may lead to severe CNS involvement with time. Currently, it classifies as the same condition as type C.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>GM1 gangliosidosis type 1 (Generalized gangliosidosis or Landing disease) results from the deficiency of beta-galactosidase at chromosome 3p22.3. A cherry-red spot in the macula occurs in around 50% of cases.<xref ref-type="bibr" rid="article-19380.r11">[11]</xref> There are three variants:
<list list-type="bullet"><list-item><p>Type I, or infantile form, is characterized by a severe disease with onset within the first year of life. Facial features are coarse with gingival hypertrophy. Other findings include developmental regression, increased startle response, skeletal anomalies, hepatosplenomegaly, intellectual disability, seizures, a cherry-red spot at the macula, corneal clouding, and death within early childhood.</p></list-item><list-item><p>Type II or the late infantile or juvenile form presents within&#x000a0;18 months or five years, respectively. The severity is less than type I, and the cherry-red spot at the macula, visceromegaly, or facial features like type I are usually not seen.</p></list-item><list-item><p>Type III or adult or chronic form is the mildest form. Features include dystonia and vertebral anomaly. The age of onset and life expectancy may be variable.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Sialidosis or mucolipidosis type 1 or alpha-neuraminidase deficiency or sialidase deficiency, or lipomucopolysaccharidosis presents with ataxia, movement disorders, nystagmus, and myoclonic seizures. There is a deficiency of neuraminidase 1 (NEU1) or sialidase (SIAL1) at chromosome 6p21.33. Intellect is usually normal, and somatic features are generally not seen. Two types have been described according to the age of onset and severity of the disease:
<list list-type="bullet"><list-item><p>Sialidosis type I, or cherry-red spot myoclonus syndrome, is characterized by onset in the 2nd or 3rd decade, gait disturbances, myoclonus, ataxia, tremor, a cherry-red spot at the macula, and seizures. The intellect and life expectancy are usually not affected, though the patient eventually needs wheelchair assistance with time. Almost all the patients have a cherry-red spot at the macula.<xref ref-type="bibr" rid="article-19380.r12">[12]</xref></p></list-item><list-item><p>Sialidosis type II causes early and more severe disease. The variants include:
<list list-type="bullet"><list-item><p>Congenital - There is either stillbirth or death&#x000a0;soon after birth.&#x000a0;Features include ascites, hydrops fetalis, coarse facial characteristics, dysostosis multiplex, and hepatosplenomegaly.</p></list-item><list-item><p>Infantile - Features are similar but milder than the congenital form. There may be short stature, gingival hyperplasia, widely spaced teeth, myoclonus, a cherry-red spot at the macula, deafness, and intellectual decline. The patients may survive into adolescence.</p></list-item><list-item><p>Juvenile form - This is the mildest variety, and life expectancy varies among the patients. Along with other features, angiokeratoma of the skin is present.</p></list-item></list>
</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Farber lipogranulomatosis -&#x000a0;Ceramidase or acid ceramidase (chromosome 8p22) is deficient in this autosomal recessive (AR) disorder. The typical triad consists of painful swollen joints, subcutaneous nodules (lipogranulomas), and a weak cry or hoarse voice due to laryngeal nodules. Other features are developmental delay, visceromegaly, respiratory involvement, and neurological features, including quadriplegia, seizures, and myoclonus.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Metachromatic leukodystrophy - There is a deficiency of arylsulfatase A, cerebroside sulfatase, or sulfatide sulfatase on chromosome 22q13 in this AR disease. An abnormal collection of sulfatides in cells producing myelin results in the progressive destruction of white matter (leukodystrophy). There is a progressive decline in intellectual and motor functions, peripheral neuropathy resulting in diminished sensations, hearing loss, incontinence, loss of speech and mobility, blindness, unresponsiveness, and eventual death. The name comes from the color of the deposited sulfatide granules on histopathological examination. A cherry-red spot at the macula is occasionally a finding.<xref ref-type="bibr" rid="article-19380.r12">[12]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Galactosialidosis (Goldberg Cotlier syndrome or neuraminidase deficiency with beta-galactosidase deficiency or cathepsin A deficiency) - This is an AR disorder due to a mutation in the CTSA gene (chromosome 20q13.12) coding for cathepsin A. The disease characteristically presents with seizures, mental retardation, growth retardation, dysostosis multiplex, coarse facies, short stature, skin hemangiomas, mitral and atrial valvular disease, and deafness. Ocular features include a cherry-red spot at the macula, corneal clouding, and conjunctival telangiectasia.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hyperalimentation causing hyperlipidemia</p>
          </list-item>
          <list-item>
            <p>Retinitis involving the central retina, including progressive outer retinal necrosis, subacute sclerosing panencephalitis<xref ref-type="bibr" rid="article-19380.r13">[13]</xref><xref ref-type="bibr" rid="article-19380.r14">[14]</xref><xref ref-type="bibr" rid="article-19380.r15">[15]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>The toxicity of various drugs may also cause a cherry-red spot. These drugs include:
<list list-type="bullet"><list-item><p>Quinine</p></list-item><list-item><p>Carbon monoxide</p></list-item><list-item><p>Dapsone poisoning associated with hemolytic anemia and peripheral neuropathy</p></list-item><list-item><p>Methanol</p></list-item><list-item><p>Intravitreal gentamicin and amikacin<xref ref-type="bibr" rid="article-19380.r16">[16]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p>The association between Gaucher disease and the presence of a cherry-red spot in the macula is questionable,&#x000a0;and the cherry-red spot at the macula is not considered a feature of Gaucher disease.<xref ref-type="bibr" rid="article-19380.r17">[17]</xref><xref ref-type="bibr" rid="article-19380.r18">[18]</xref></p>
      </sec>
      <sec id="article-19380.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>A cherry-red spot at the macula is a rare finding, and the epidemiology depends on the cause. Tay-Sachs disease is estimated to affect 1 in 320000 newborns.<xref ref-type="bibr" rid="article-19380.r19">[19]</xref> The true epidemiology of central retinal arterial occlusion is unknown. A study estimated that&#x000a0;acute central retinal arterial occlusion (duration less than 48 hours) affects approximately 0.85 per 100000 per year or 1.13 per 10000 outpatient visits.<xref ref-type="bibr" rid="article-19380.r20">[20]</xref></p>
      </sec>
      <sec id="article-19380.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The macula is characterized histologically by an area with more than one layer of ganglion cell layers, and the ganglion cell layer is thick at the macula. In diseases causing loss of transparency (whitening or opacification) of the inner retina, the&#x000a0;reddish color of the vascular choroid and pigmentation of retinal pigment epithelium (RPE) is not seen through the opacified retina. However, the foveola is devoid of the inner retinal layer. The retinal layers present at the foveola are (from inside outwards)- the internal limiting membrane, outer nuclear layer, external&#x000a0;limiting membrane, photoreceptor layer, and RPE. Inner retinal layers are absent in mature foveola. The vascular supply of the fovea is from the choroid, and in the occlusion of retinal vessels, it does not get hampered. Thus foveola, the thinnest part of the central retina, does not lose its transparency in inner retinal ischemia.</p>
        <p>Thus, when there is inner retinal opacification, the reddish color of the vascular choroid and the RPE is still seen through the foveola, which is surrounded by an area of the white/opacified retina; this gives rise to the typical cherry-red spot. The size of the cherry-red spot depends on the size of the foveola.&#x000a0;</p>
        <p>As the color of choroid and RPE varies with racial variation, the color of the foveola or the central dot may change according to race. A true cherry-red spot presents in whites. The color of foveola was brown, causing a cherry brown spot in a Canadian aboriginal child with Sandhoff disease, and black in a patient of east Indian race creating a cherry black spot in Sandhoff disease.<xref ref-type="bibr" rid="article-19380.r21">[21]</xref>&#x000a0;Thus an alternate name of 'perifoveal white patch' has been suggested.<xref ref-type="bibr" rid="article-19380.r21">[21]</xref></p>
        <p>Therefore for a cherry-red spot to be seen, the vascularity of the choroid needs to be intact. In cases of ophthalmic artery occlusion,&#x000a0;there is a compromise to the vascular supply to the eye, and even the choroid is not perfused.&#x000a0;In such cases, a cherry red spot at the macula may not be seen.</p>
        <p>The opacification of inner retinal may be due to the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Retinal ischemia due to occlusion of the central retinal artery- The retinal whitening is typically most prominent in the posterior pole, and the opaque retina obscures the details of the choroidal vessels. The whitening of the retina becomes less prominent a little peripheral to the arcades, which may be related to the reduced inner retinal thickness at the peripheral retina. There is a cessation of axoplasmic transport&#x000a0;and the opacification of both the ganglion cell and the nerve fiber layer in a CRAO.</p>
          </list-item>
          <list-item>
            <p>Deposition or accumulation of material in the ganglion cell layer- In Tay-Sachs disease and other lipid storage disorders (sphingolipidoses), there is a progressive abnormal excessive intracellular accumulation of various glycolipids/phospholipids in the ganglion cell layer leading to opacification of the inner retina. The foveola is devoid of the ganglion cell layer and hence remains transparent and allows transmission of the color of the choroid and the RPE. However, the damaged ganglion cells are lost with increasing age, and the cherry-red spot becomes less prominent. In such cases, the optic disc has consecutive optic atrophy and pallor due to the degeneration of the ganglion cell layer and nerve fiber layer.</p>
          </list-item>
        </list>
        <p>Other causes of retinal whitening include retinitis and trauma (commotion retinae). Sphingolipidoses are disorders of lysosomal metabolism, which involve conjugated&#x000a0;products of ceramide and sugar or phospholipids. Sphingolipidoses include gangliosidosis, Niemann-Pick disease, Farber disease, and metachromatic leukodystrophy.</p>
      </sec>
      <sec id="article-19380.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Tay-Sachs disease demonstrates an accumulation of GM2 gangliosides in the brain, spinal cord, and ganglion cells of the retina.<xref ref-type="bibr" rid="article-19380.r22">[22]</xref> Typically, a ballooned appearance of the neurons is a feature that has vacuoles in the cytoplasm composed of distended lysosomes filled with gangliosides. Stain with oil red O or Sudan black B is positive.<xref ref-type="bibr" rid="article-19380.r23">[23]</xref></p>
        <p>Electron microscopy reveals whorled deposits within the lysosome, which have a multilayered appearance like a cut section of an onion.<xref ref-type="bibr" rid="article-19380.r22">[22]</xref>&#x000a0;In CRAO, the early changes are ischemic changes and swelling of the inner retina, which is followed by thinning of inner retinal layers with time.<xref ref-type="bibr" rid="article-19380.r24">[24]</xref></p>
      </sec>
      <sec id="article-19380.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Central retinal artery occlusion usually presents with sudden onset vision loss in the elderly. Usually, there is a relative afferent pupillary defect in the affected eye.<xref ref-type="bibr" rid="article-19380.r25">[25]</xref> The fundus examination reveals a whitened opaque retina at the posterior pole blocking the visibility of the choroidal vessels. The foveola remains transparent, giving rise to the cherry-red spot. Other features include fragmentation of blood column in retinal vessels ("boxcarring"), which may be noted to move sluggishly on prolonged observation. An embolus within the central retinal artery or its branches may be present. In the late phase, retinal thinning, pigmentary changes at the fovea, and optic atrophy may occur.</p>
        <p>In lipid storage disorders, there might be evidence of neurodegeneration and visceromegaly. In the early phase, there is a perifoveal white donut-like area around the fovea with a cherry-red spot appearance. In the late phase, there is atrophy of inner retinal layers, the disappearance of the cherry-red spot, and optic atrophy. Family history and examination of family members are of paramount importance. Commotio retinae patients have a history of blunt trauma. Signs of blunt trauma, including hyphema, anterior uveitis, and damage to the seven rings of trauma, may be visible. Retinitis may be associated with intraocular inflammation, vitritis, and retinal necrosis that is more prominently visible on the optical coherence tomography scan.<xref ref-type="bibr" rid="article-19380.r26">[26]</xref><xref ref-type="bibr" rid="article-19380.r27">[27]</xref><xref ref-type="bibr" rid="article-19380.r28">[28]</xref></p>
      </sec>
      <sec id="article-19380.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Color fundus photo helps in documenting the fundus features, counseling the patients, and evaluating the progression of the disease and treatment response.<xref ref-type="bibr" rid="article-19380.r29">[29]</xref></p>
        <p>Fundus fluorescein angiography (FFA)<xref ref-type="bibr" rid="article-19380.r30">[30]</xref> shows delayed arterial circulation, a slowly progressing front edge of the dye, and late filling of the retinal veins in CRAO. There may be an abrupt ending to the flow of the dye at the location of an embolus in the central retinal artery or its branches. The FFA may even be normal in reperfused retinas in CRAO or transient CRAO.<xref ref-type="bibr" rid="article-19380.r3">[3]</xref>&#x000a0;FFA may show an area of hypofluorescence (block fluorescence) 360 degrees around the foveola in lipid storage disorders.<xref ref-type="bibr" rid="article-19380.r31">[31]</xref></p>
        <p>The optical coherence tomography (OCT) of the macula in CRAO shows hyperreflectivity of inner retinal layers and retinal thickening. In lipid storage disorders, there is hyperreflectivity of the nerve fiber layer and the ganglion cell layer on OCT.<xref ref-type="bibr" rid="article-19380.r32">[32]</xref> In commotio retinae, OCT usually does not show an increased retinal thickness. Still, there may be hyperreflectivity of the inner segment-outer segment (IS-OS) junction with or without defects in the IS-OS junction, external limiting membrane (ELM), or cone outer segment tips (COST) line.<xref ref-type="bibr" rid="article-19380.r33">[33]</xref></p>
        <p>Autofluorescence may show hyper autofluorescence around the fovea in sialidosis.<xref ref-type="bibr" rid="article-19380.r34">[34]</xref>&#x000a0;In CRAO, there is hypo autofluorescence in the area of retinal whitening.<xref ref-type="bibr" rid="article-19380.r35">[35]</xref></p>
        <p>In suspected lipid storage disorder, evaluation for enzyme deficiency and multisystem involvement is essential. In retinitis, evaluation includes tests for&#x000a0;immune status, neurological examination for some patients, and, if needed, vitreous or aqueous tap to look for various infectious etiologies.<xref ref-type="bibr" rid="article-19380.r26">[26]</xref></p>
      </sec>
      <sec id="article-19380.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The management of a cherry-red spot&#x000a0;depends on the cause.</p>
        <p>For CRAO, the options for management when the present patients early include ocular massage, anterior chamber paracentesis, reduction of intraocular pressure by systemic and topical medications, hyperbaric oxygen therapy, and intraarterial thrombolysis. These acute measures may provide benefits; however, there is no clear evidence at this point that these measures improve the patient's final visual acuity.<xref ref-type="bibr" rid="article-19380.r36">[36]</xref>&#x000a0;Intravenous pulse steroid forms the mainstay of treatment for GCA-related CRAO to prevent vision loss in the fellow eye.</p>
        <p>For various storage diseases, management requires a team of various specialties. Generalized pearls for managing such patients include avoiding/reducing intake of specific molecules,&#x000a0;enzyme replacement therapy, and symptomatic management.</p>
        <p>Retinitis patients will need individualized therapy based on the clinical characteristics, imaging features, and results of investigations.<xref ref-type="bibr" rid="article-19380.r26">[26]</xref><xref ref-type="bibr" rid="article-19380.r27">[27]</xref><xref ref-type="bibr" rid="article-19380.r28">[28]</xref><xref ref-type="bibr" rid="article-19380.r37">[37]</xref><xref ref-type="bibr" rid="article-19380.r38">[38]</xref>&#x000a0;Patients with commotio retinae or Berlin's edema&#x000a0;should be examined thoroughly to look for traumatic optic neuropathy, uveitis, hyphema, iris-sphincter tears, iridodialysis, retinal dialysis, and other evidence of trauma. The associated ocular injuries should be treated and may need topical or systemic steroids. Most cases with commotio retinae resolve spontaneously.<xref ref-type="bibr" rid="article-19380.r39">[39]</xref><xref ref-type="bibr" rid="article-19380.r26">[26]</xref></p>
      </sec>
      <sec id="article-19380.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>&#x000a0;The possible differential diagnoses of cherry red spot include</p>
        <list list-type="bullet">
          <list-item>
            <p>Macular hole</p>
          </list-item>
          <list-item>
            <p>Macular pseudohole</p>
          </list-item>
          <list-item>
            <p>Laser injury to the fovea</p>
          </list-item>
          <list-item>
            <p>Macular telangiectasia type 2</p>
          </list-item>
          <list-item>
            <p>Choroidal neovascular membrane</p>
          </list-item>
          <list-item>
            <p>Macular hemorrhage<xref ref-type="bibr" rid="article-19380.r40">[40]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19380.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of a cherry-red spot at the macula varies according to the cause. Most cases of commotion retinae resolve with time, and visual recovery is usually good. CRAO and macular infarction, on the other hand, has a poor visual prognosis, and these eyes may&#x000a0;become painful blind eyes due to neovascular glaucoma. Cases with progressive outer retinal necrosis (PORN) usually lose perception of light. Tay Sachs disease is usually fatal by five years of age.</p>
      </sec>
      <sec id="article-19380.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of a cherry red spot at the macula will depend on the cause. In CRAO, atrophy of the retina and optic&#x000a0;disc usually ensues in the long term. Commotio retinae may rarely be followed by pigmentary retinopathy and retinal thinning. In cases with lipid storage disorder, optic nerve pallor and retinal thinning may appear as time progresses. Retinal detachments may complicate cases with necrotizing retinitis.</p>
      </sec>
      <sec id="article-19380.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The cause, prognosis, and management must be discussed with the patients with cherry red spots at the macula. Possible life-threatening or vision-threatening implications should be explained in detail so the patient can make an informed decision about their treatment. Genetic counseling is crucial for lipid storage disorders. For CRAO, control of vascular risk factors is of paramount importance.</p>
      </sec>
      <sec id="article-19380.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Ruling out serious life-threatening or sight-threatening diseases is of paramount importance in a patient with a cherry-red spot at the macula. The management varies according to the cause. When the primary care provider, including PAs and NPs, pediatricians, or emergency department physicians, encounters patients with vision alterations, referral to an ophthalmologist is a strong recommendation. Given the variety of potential etiologies for this condition, an interprofessional team approach involving clinicians and nursing professionals is the best way to ensure proper diagnosis and treatment for the underlying disease state. Nurse specialists in ophthalmology and genetics coordinate the care, monitoring, and education of patients and their families. This interprofessional team approach can improve patient outcomes. [Level 5]</p>
      </sec>
      <sec id="article-19380.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19380&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19380">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/cherry-red-spot/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=19380">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19380/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19380">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-19380.s16">
        <fig id="article-19380.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Tay-Sachs Disease. This image of a fundus reveals a cherry-red spot in a 9-month-old boy with Tay-Sachs disease. Contributed by B Parayil Sankaran MD, DM, FRACP, PhD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Fig.1.Tay__Sachs.Cherry__Red__spot" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19380.s17">
        <fig id="article-19380.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Central Retinal Arterial Occlusion- right eye Contributed by Koushik Tripathy, MD, FRCS (G)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CRAO" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19380.s18">
        <fig id="article-19380.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Commotio Retinae With Foveal Involvement. This image displays the commotio retinae of a patient with foveal involvement, also known as Berlin edema. Contributed by K Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Commotio__retinae__Berlin__edema" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-19380.s19">
        <title>References</title>
        <ref id="article-19380.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Acute retinal arterial occlusive disorders.</article-title>
            <source>Prog Retin Eye Res</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>359</fpage>
            <page-range>359-94</page-range>
            <pub-id pub-id-type="pmid">21620994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mazumdar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sarma</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Central retinal arterial occlusion in a patient with pyoderma gangrenosum.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>66</volume>
            <issue>7</issue>
            <fpage>1019</fpage>
            <page-range>1019-1021</page-range>
            <pub-id pub-id-type="pmid">29941761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Fundus changes in central retinal artery occlusion.</article-title>
            <source>Retina</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>276</fpage>
            <page-range>276-89</page-range>
            <pub-id pub-id-type="pmid">17460582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jung</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Iatrogenic Central Retinal Artery Occlusion Following Retrobulbar Anesthesia for Intraocular Surgery.</article-title>
            <source>Korean J Ophthalmol</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>233</fpage>
            <page-range>233-40</page-range>
            <pub-id pub-id-type="pmid">26240507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasavada</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baskaran</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ramakrishnan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Retinal Vascular Occlusion Secondary to Retrobulbar Injection: Case Report and Literature Review.</article-title>
            <source>Middle East Afr J Ophthalmol</source>
            <year>2017</year>
            <season>Jan-Mar</season>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-60</page-range>
            <pub-id pub-id-type="pmid">28546695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhao</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Unilateral isolated optic nerve infiltration combined with central retinal artery occlusion in a patient with acute myeloid leukemia.</article-title>
            <source>Am J Ophthalmol Case Rep</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>26</volume>
            <fpage>101493</fpage>
            <pub-id pub-id-type="pmid">35321253</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kumawat</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>YR</given-names>
              </name>
              <name>
                <surname>Bypareddy</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Acute Vision Loss Due to Central Retinal Arterial Occlusion, Partial Optic Nerve Avulsion, and Hemorrhage "Spurting Out" from Optic Disc after Blunt Trauma.</article-title>
            <source>J Ophthalmic Vis Res</source>
            <year>2017</year>
            <season>Jul-Sep</season>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>351</fpage>
            <page-range>351-352</page-range>
            <pub-id pub-id-type="pmid">28791073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rajput</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sawhney</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sardana</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Macular infarction and traumatic optic neuropathy following blunt ocular trauma.</article-title>
            <source>Saudi J Ophthalmol</source>
            <year>2016</year>
            <season>Jan-Mar</season>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-5</page-range>
            <pub-id pub-id-type="pmid">26949360</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahmed</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gogia</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Choroidal coloboma in a case of tay-sachs disease.</article-title>
            <source>Case Rep Ophthalmol Med</source>
            <year>2014</year>
            <volume>2014</volume>
            <fpage>760746</fpage>
            <pub-id pub-id-type="pmid">25295204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Extensive commotio retinae involving peripheral retina.</article-title>
            <source>Natl Med J India</source>
            <year>2017</year>
            <season>Jul-Aug</season>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>242</fpage>
            <pub-id pub-id-type="pmid">29162764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>DU</given-names>
              </name>
              <name>
                <surname>Mandal</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2014</year>
            <season>Jan-Feb</season>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <page-range>64-76</page-range>
            <pub-id pub-id-type="pmid">24011710</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suvarna</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Hajela</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Cherry-red spot.</article-title>
            <source>J Postgrad Med</source>
            <year>2008</year>
            <season>Jan-Mar</season>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-7</page-range>
            <pub-id pub-id-type="pmid">18296811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Farmania</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gulati</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmic examination as a means to diagnose Subacute Sclerosing Panencephalitis: an optical coherence tomography and ultrawide field imaging evaluation.</article-title>
            <source>Eye Vis (Lond)</source>
            <year>2017</year>
            <volume>4</volume>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">28116334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gogia</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Progressive outer retinal necrosis-like retinitis in immunocompetent hosts.</article-title>
            <source>BMJ Case Rep</source>
            <year>2016</year>
            <month>Aug</month>
            <day>10</day>
            <volume>2016</volume>
            <pub-id pub-id-type="pmid">27511757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yiu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Progressive outer retinal necrosis presenting as cherry red spot.</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>5</issue>
            <fpage>384</fpage>
            <page-range>384-6</page-range>
            <pub-id pub-id-type="pmid">22957726</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abhayambika</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chacko</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mahadevan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Najeeb</surname>
                <given-names>OM</given-names>
              </name>
            </person-group>
            <article-title>Peripheral neuropathy and haemolytic anaemia with cherry red spot on macula in dapsone poisoning.</article-title>
            <source>J Assoc Physicians India</source>
            <year>1990</year>
            <month>Aug</month>
            <volume>38</volume>
            <issue>8</issue>
            <fpage>564</fpage>
            <page-range>564-5</page-range>
            <pub-id pub-id-type="pmid">2174032</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goker-Alpan</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Schiffmann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Stubblefield</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Tayebi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sidransky</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3.</article-title>
            <source>J Pediatr</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>143</volume>
            <issue>2</issue>
            <fpage>273</fpage>
            <page-range>273-6</page-range>
            <pub-id pub-id-type="pmid">12970647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winter</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Salimi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ospina</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Roos</surname>
                <given-names>JCP</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmic manifestations of Gaucher disease: the most common lysosomal storage disorder.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>103</volume>
            <issue>3</issue>
            <fpage>315</fpage>
            <page-range>315-326</page-range>
            <pub-id pub-id-type="pmid">30612093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lew</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Burnett</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Proos</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Delatycki</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Tay-Sachs disease: current perspectives from Australia.</article-title>
            <source>Appl Clin Genet</source>
            <year>2015</year>
            <volume>8</volume>
            <fpage>19</fpage>
            <page-range>19-25</page-range>
            <pub-id pub-id-type="pmid">25653550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rumelt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dorenboim</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Rehany</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Aggressive systematic treatment for central retinal artery occlusion.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>128</volume>
            <issue>6</issue>
            <fpage>733</fpage>
            <page-range>733-8</page-range>
            <pub-id pub-id-type="pmid">10612510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ospina</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Lyons</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>McCormick</surname>
                <given-names>AQ</given-names>
              </name>
            </person-group>
            <article-title>"Cherry-red spot" or "perifoveal white patch"?</article-title>
            <source>Can J Ophthalmol</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>40</volume>
            <issue>5</issue>
            <fpage>609</fpage>
            <page-range>609-10</page-range>
            <pub-id pub-id-type="pmid">16391625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r22">
          <label>22</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ramani</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Parayil Sankaran</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <chapter-title>Tay-Sachs Disease</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>1</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">33232090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferreira</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Gahl</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Lysosomal storage diseases.</article-title>
            <source>Transl Sci Rare Dis</source>
            <year>2017</year>
            <month>May</month>
            <day>25</day>
            <volume>2</volume>
            <issue>1-2</issue>
            <fpage>1</fpage>
            <page-range>1-71</page-range>
            <pub-id pub-id-type="pmid">29152458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sanon</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Central retinal artery occlusion. Retinal survival time.</article-title>
            <source>Exp Eye Res</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>78</volume>
            <issue>3</issue>
            <fpage>723</fpage>
            <page-range>723-36</page-range>
            <pub-id pub-id-type="pmid">15106952</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r25">
          <label>25</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Simakurthy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Marcus Gunn Pupil</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">32491607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r26">
          <label>26</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gupta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Retinitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>5</month>
            <day>1</day>
            <pub-id pub-id-type="pmid">32809355</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r27">
          <label>27</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Geetha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Chorioretinitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">31869169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r28">
          <label>28</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bergstrom</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Acute Retinal Necrosis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">29262034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r29">
          <label>29</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mishra</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Fundus Camera</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">36256758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r30">
          <label>30</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ruia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Fluorescein Angiography</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35015403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heroman</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Rychwalski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Barr</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Cherry red spot in sialidosis (mucolipidosis type I).</article-title>
            <source>Arch Ophthalmol</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>126</volume>
            <issue>2</issue>
            <fpage>270</fpage>
            <page-range>270-1</page-range>
            <pub-id pub-id-type="pmid">18268224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Kao</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>Optical coherence tomography features in a case of Type I sialidosis.</article-title>
            <source>Taiwan J Ophthalmol</source>
            <year>2017</year>
            <season>Apr-Jun</season>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>108</fpage>
            <page-range>108-111</page-range>
            <pub-id pub-id-type="pmid">29018767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahn</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Jo</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Ahn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>KH</given-names>
              </name>
            </person-group>
            <article-title>Optical coherence tomography morphologic grading of macular commotio retinae and its association with anatomic and visual outcomes.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>156</volume>
            <issue>5</issue>
            <fpage>994</fpage>
            <page-range>994-1001.e1</page-range>
            <pub-id pub-id-type="pmid">23972302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zou</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Fundus autofluorescence and optical coherence tomography of a macular cherry-red spot in a case report of sialidosis.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2016</year>
            <month>Mar</month>
            <day>22</day>
            <volume>16</volume>
            <fpage>30</fpage>
            <pub-id pub-id-type="pmid">27004518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mathew</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Papavasileiou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sivaprasad</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Autofluorescence and high-definition optical coherence tomography of retinal artery occlusions.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2010</year>
            <month>Oct</month>
            <day>21</day>
            <volume>4</volume>
            <fpage>1159</fpage>
            <page-range>1159-63</page-range>
            <pub-id pub-id-type="pmid">21060665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varma</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Cugati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>A review of central retinal artery occlusion: clinical presentation and management.</article-title>
            <source>Eye (Lond)</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>688</fpage>
            <page-range>688-97</page-range>
            <pub-id pub-id-type="pmid">23470793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Cytomegaloviral retinitis.</article-title>
            <source>Natl Med J India</source>
            <year>2016</year>
            <season>Jan-Feb</season>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <pub-id pub-id-type="pmid">27492038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Temkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>An imaging-based treatment algorithm for posterior focal retinitis.</article-title>
            <source>Ther Adv Ophthalmol</source>
            <year>2018</year>
            <season>Jan-Dec</season>
            <volume>10</volume>
            <fpage>2515841418774423</fpage>
            <pub-id pub-id-type="pmid">29998221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Nam</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Jang</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Ohn</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of the central macula in commotio retinae not associated with other types of traumatic retinopathy.</article-title>
            <source>Korean J Ophthalmol</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>262</fpage>
            <page-range>262-7</page-range>
            <pub-id pub-id-type="pmid">21860574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19380.r40">
          <label>40</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Majumdar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Macular Hole</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">32644626</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
